10 years ago, St. Jude took on pediatric cancer genome, and won
Dr. James Downing, president and CEO of St. Jude Children's Research Hospital, has been instrumental in the development and refinement of St. Jude's genomic sequencing operations for pediatric cancer. (Patrick Lantrip/Daily Memphian)
Among the findings was genetic coding that proved there is more than a passing chance that some cancers are inherited.
Topics
Dr. James Downing St. Jude Children’s Research Hospital Pediatric Cancer Genome ProjectJane Roberts
Jane Roberts has reported in Memphis for more than 20 years. As a senior member of The Daily Memphian staff, she was assigned to the medical beat during the COVID-19 pandemic. She also has done in-depth work on other medical issues facing our community, including shortages of specialists in local hospitals. She covered K-12 education here for years and later the region’s transportation sector, including Memphis International Airport and FedEx Corp.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.